This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


1zls

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:1zls.gif|left|200px]]
+
{{Seed}}
 +
[[Image:1zls.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1zls| PDB=1zls | SCENE= }}
{{STRUCTURE_1zls| PDB=1zls | SCENE= }}
-
'''FAB 2G12 + Man4'''
+
===FAB 2G12 + Man4===
-
==Overview==
+
<!--
-
Human antibody 2G12 neutralizes a broad range of HIV-1 isolates. Hence, molecular characterization of its epitope, which corresponds to a conserved cluster of oligomannoses on the viral envelope glycoprotein gp120, is a high priority in HIV vaccine design. A prior crystal structure of 2G12 in complex with Man(9)GlcNAc(2) highlighted the central importance of the D1 arm in antibody binding. To characterize the specificity of 2G12 more precisely, we performed solution-phase ELISA, carbohydrate microarray analysis, and cocrystallized Fab 2G12 with four different oligomannose derivatives (Man(4), Man(5), Man(7), and Man(8)) that compete with gp120 for binding to 2G12. Our combined studies reveal that 2G12 is capable of binding both the D1 and D3 arms of the Man(9)GlcNAc(2) moiety, which would provide more flexibility to make the required multivalent interactions between the antibody and the gp120 oligomannose cluster than thought previously. These results have important consequences for the design of immunogens to elicit 2G12-like neutralizing antibodies as a component of an HIV vaccine.
+
The line below this paragraph, {{ABSTRACT_PUBMED_16174734}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 16174734 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_16174734}}
==About this Structure==
==About this Structure==
Line 31: Line 35:
[[Category: Domain-swapping]]
[[Category: Domain-swapping]]
[[Category: Hiv neutralizing antibody]]
[[Category: Hiv neutralizing antibody]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 17:46:49 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Jul 27 16:03:22 2008''

Revision as of 13:03, 27 July 2008

Image:1zls.png

Template:STRUCTURE 1zls

FAB 2G12 + Man4

Template:ABSTRACT PUBMED 16174734

About this Structure

Full crystallographic information is available from OCA.

Reference

Dissection of the carbohydrate specificity of the broadly neutralizing anti-HIV-1 antibody 2G12., Calarese DA, Lee HK, Huang CY, Best MD, Astronomo RD, Stanfield RL, Katinger H, Burton DR, Wong CH, Wilson IA, Proc Natl Acad Sci U S A. 2005 Sep 20;102(38):13372-7. Epub 2005 Sep 7. PMID:16174734

Page seeded by OCA on Sun Jul 27 16:03:22 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/1zls"
Personal tools